These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 11403931)

  • 1. Complement activation by neurofibrillary tangles in Alzheimer's disease.
    Shen Y; Lue L; Yang L; Roher A; Kuo Y; Strohmeyer R; Goux WJ; Lee V; Johnson GV; Webster SD; Cooper NR; Bradt B; Rogers J
    Neurosci Lett; 2001 Jun; 305(3):165-8. PubMed ID: 11403931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of the carboxyl terminal sequence of tau in ghost tangles of Alzheimer's disease.
    Endoh R; Ogawara M; Iwatsubo T; Nakano I; Mori H
    Brain Res; 1993 Jan; 601(1-2):164-72. PubMed ID: 8431763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain.
    Conn KJ; Pietropaolo M; Ju ST; Abraham CR
    J Neurochem; 1996 May; 66(5):2011-8. PubMed ID: 8780030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of caspase cleavage of tau in Alzheimer disease neuropathology.
    Cotman CW; Poon WW; Rissman RA; Blurton-Jones M
    J Neuropathol Exp Neurol; 2005 Feb; 64(2):104-12. PubMed ID: 15751224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease.
    Rostagno A; Revesz T; Lashley T; Tomidokoro Y; Magnotti L; Braendgaard H; Plant G; Bojsen-Møller M; Holton J; Frangione B; Ghiso J
    J Biol Chem; 2002 Dec; 277(51):49782-90. PubMed ID: 12388551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
    Carter CJ
    Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurofibrillary Tangles of Aβx-40 in Alzheimer's Disease Brains.
    Lacosta AM; Insua D; Badi H; Pesini P; Sarasa M
    J Alzheimers Dis; 2017; 58(3):661-667. PubMed ID: 28453491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins.
    Schwab C; Steele JC; McGeer PL
    Brain Res; 1996 Jan; 707(2):196-205. PubMed ID: 8919296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First insert of tau protein is present in all stages of tau pathology in Alzheimer's disease.
    Soltys K; Rolkova G; Vechterova L; Filipcik P; Zilka N; Kontsekova E; Novak M
    Neuroreport; 2005 Oct; 16(15):1677-81. PubMed ID: 16189476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A; Döbeli H; Bohrmann B
    Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of neurofibrillary tangles in Alzheimer disease.
    Brion JP
    Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid precursor protein cytoplasmic domain with phospho-Thr668 accumulates in Alzheimer's disease and its transgenic models: a role to mediate interaction of Abeta and tau.
    Shin RW; Ogino K; Shimabuku A; Taki T; Nakashima H; Ishihara T; Kitamoto T
    Acta Neuropathol; 2007 Jun; 113(6):627-36. PubMed ID: 17431643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer's Disease-Related Pathology.
    Terni B; Ferrer I
    J Alzheimers Dis; 2015; 46(2):461-9. PubMed ID: 26402409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alzheimer disease: cellular and molecular aspects].
    Octave JN
    Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease.
    Dugger BN; Whiteside CM; Maarouf CL; Walker DG; Beach TG; Sue LI; Garcia A; Dunckley T; Meechoovet B; Reiman EM; Roher AE
    J Alzheimers Dis; 2016; 51(2):345-56. PubMed ID: 26890756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibrillary tangles and Alzheimer's disease.
    Brion JP
    Eur Neurol; 1998 Oct; 40(3):130-40. PubMed ID: 9748670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline.
    Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B
    Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive neuronal DNA damage associated with neurofibrillary tangle formation in Alzheimer disease.
    Sheng JG; Mrak RE; Griffin WS
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):323-8. PubMed ID: 9600224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating antibodies against tau protein in its unphosphorylated and in its neurofibrillary tangles-related phosphorylated state in Alzheimer's disease and healthy subjects.
    Rosenmann H; Meiner Z; Geylis V; Abramsky O; Steinitz M
    Neurosci Lett; 2006 Dec; 410(2):90-3. PubMed ID: 17095156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation by beta-amyloid in Alzheimer disease.
    Rogers J; Cooper NR; Webster S; Schultz J; McGeer PL; Styren SD; Civin WH; Brachova L; Bradt B; Ward P
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10016-20. PubMed ID: 1438191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.